Home > > > > > Report Detail

Global Contraceptives Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 09-Sep-2022
No. of pages: 126
Inquire Before Buying

Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Contraceptives market is projected to reach US$ 2277.4 million by 2028 from an estimated US$ 1963.8 million in 2022, at a CAGR of 2.5% during 2023 and 2028.

Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share.

The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine etc. Top 3 companies occupied about 46% market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Contraceptives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Contraceptives.

The Contraceptives market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Contraceptives market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Contraceptives manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Bayer AG

- Pfizer, Inc

- Teva Pharmaceutical Industries Ltd

- Merck & Co., Inc

- Actavis, Inc.

- Johnson & Johnson

- Gedeon Richter

- Novo Nordisk A/S

- ZiZhu

- Baijingyu

- Huazhong

- Sine

- Reckitt

- AbbVie

- Church & Dwight

- The Cooper Companies

- TherapeuticsMD

- Afaxys

- Mithra Pharmaceuticals

Product Type Insights

Global markets are presented by Contraceptives type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Contraceptives are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Contraceptives Segment by Type

- Pills

- Injectable

- Condoms

- Vaginal Rings

- IUDs

- Subdermal Implants

- Others

Application Insights

This report has provided the market size (sales and revenue data) by end user, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Contraceptives market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Contraceptives market.

Contraceptives Segment by End User

- 15-24 years

- 25-34 years

- 35-44 years

- Above 44 years

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Contraceptives market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Contraceptives and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Contraceptives industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptives

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

Global Contraceptives Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Contraceptives Product Introduction
1.2 Market by Type
1.2.1 Global Contraceptives Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Pills
1.2.3 Injectable
1.2.4 Condoms
1.2.5 Vaginal Rings
1.2.6 IUDs
1.2.7 Subdermal Implants
1.2.8 Others
1.3 Market by End User
1.3.1 Global Contraceptives Market Size Growth Rate by End User (2017 VS 2021 VS 2028)
1.3.2 15-24 years
1.3.3 25-34 years
1.3.4 35-44 years
1.3.5 Above 44 years
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Contraceptives Market Size Estimates and Forecasts
2.1.1 Global Contraceptives Revenue 2017-2028
2.1.2 Global Contraceptives Sales 2017-2028
2.2 Contraceptives Market Size by Region: 2022 Versus 2028
2.3 Contraceptives Sales by Region (2017-2028)
2.3.1 Global Contraceptives Sales by Region: 2017-2022
2.3.2 Global Contraceptives Sales Forecast by Region (2023-2028)
2.3.3 Global Contraceptives Sales Market Share by Region (2017-2028)
2.4 Contraceptives Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Contraceptives Revenue by Region: 2017-2022
2.4.2 Global Contraceptives Revenue Forecast by Region (2023-2028)
2.4.3 Global Contraceptives Revenue Market Share by Region (2017-2028)
3 Global Contraceptives by Manufacturers
3.1 Global Top Contraceptives Manufacturers by Sales
3.1.1 Global Contraceptives Sales by Manufacturer (2017-2022)
3.1.2 Global Contraceptives Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Contraceptives Manufacturers by Revenue
3.2.1 Global Contraceptives Revenue by Manufacturer (2017-2022)
3.2.2 Global Contraceptives Revenue Share by Manufacturer (2017-2022)
3.3 Global Contraceptives Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Contraceptives Manufacturers Covered: Ranking by Revenue
3.4.2 Global Contraceptives Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Contraceptives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Contraceptives Manufacturing Base Distribution, Product Type
3.5.1 Contraceptives Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Contraceptives Product Type
3.5.3 Date of International Manufacturers Enter into Contraceptives Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Bayer AG
4.1.1 Bayer AG Corporation Information
4.1.2 Bayer AG Description, Business Overview
4.1.3 Bayer AG Contraceptives Products Offered
4.1.4 Bayer AG Contraceptives Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Bayer AG Contraceptives Sales by Product in 2021
4.1.6 Bayer AG Contraceptives Sales by End User in 2021
4.1.7 Bayer AG Contraceptives Sales by Geographic Area in 2021
4.1.8 Bayer AG Recent Developments
4.2 Pfizer, Inc
4.2.1 Pfizer, Inc Corporation Information
4.2.2 Pfizer, Inc Description, Business Overview
4.2.3 Pfizer, Inc Contraceptives Products Offered
4.2.4 Pfizer, Inc Contraceptives Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Pfizer, Inc Contraceptives Sales by Product in 2021
4.2.6 Pfizer, Inc Contraceptives Sales by End User in 2021
4.2.7 Pfizer, Inc Contraceptives Sales by Geographic Area in 2021
4.2.8 Pfizer, Inc Recent Developments
4.3 Teva Pharmaceutical Industries Ltd
4.3.1 Teva Pharmaceutical Industries Ltd Corporation Information
4.3.2 Teva Pharmaceutical Industries Ltd Description, Business Overview
4.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Products Offered
4.3.4 Teva Pharmaceutical Industries Ltd Contraceptives Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Teva Pharmaceutical Industries Ltd Contraceptives Sales by Product in 2021
4.3.6 Teva Pharmaceutical Industries Ltd Contraceptives Sales by End User in 2021
4.3.7 Teva Pharmaceutical Industries Ltd Contraceptives Sales by Geographic Area in 2021
4.3.8 Teva Pharmaceutical Industries Ltd Recent Developments
4.4 Merck & Co., Inc
4.4.1 Merck & Co., Inc Corporation Information
4.4.2 Merck & Co., Inc Description, Business Overview
4.4.3 Merck & Co., Inc Contraceptives Products Offered
4.4.4 Merck & Co., Inc Contraceptives Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Merck & Co., Inc Contraceptives Sales by Product in 2021
4.4.6 Merck & Co., Inc Contraceptives Sales by End User in 2021
4.4.7 Merck & Co., Inc Contraceptives Sales by Geographic Area in 2021
4.4.8 Merck & Co., Inc Recent Developments
4.5 Actavis, Inc.
4.5.1 Actavis, Inc. Corporation Information
4.5.2 Actavis, Inc. Description, Business Overview
4.5.3 Actavis, Inc. Contraceptives Products Offered
4.5.4 Actavis, Inc. Contraceptives Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Actavis, Inc. Contraceptives Sales by Product in 2021
4.5.6 Actavis, Inc. Contraceptives Sales by End User in 2021
4.5.7 Actavis, Inc. Contraceptives Sales by Geographic Area in 2021
4.5.8 Actavis, Inc. Recent Developments
4.6 Johnson & Johnson
4.6.1 Johnson & Johnson Corporation Information
4.6.2 Johnson & Johnson Description, Business Overview
4.6.3 Johnson & Johnson Contraceptives Products Offered
4.6.4 Johnson & Johnson Contraceptives Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Johnson & Johnson Contraceptives Sales by Product in 2021
4.6.6 Johnson & Johnson Contraceptives Sales by End User in 2021
4.6.7 Johnson & Johnson Contraceptives Sales by Geographic Area in 2021
4.6.8 Johnson & Johnson Recent Development
4.7 Gedeon Richter
4.7.1 Gedeon Richter Corporation Information
4.7.2 Gedeon Richter Description, Business Overview
4.7.3 Gedeon Richter Contraceptives Products Offered
4.7.4 Gedeon Richter Contraceptives Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Gedeon Richter Contraceptives Sales by Product in 2021
4.7.6 Gedeon Richter Contraceptives Sales by End User in 2021
4.7.7 Gedeon Richter Contraceptives Sales by Geographic Area in 2021
4.7.8 Gedeon Richter Recent Development
4.8 Novo Nordisk A/S
4.8.1 Novo Nordisk A/S Corporation Information
4.8.2 Novo Nordisk A/S Description, Business Overview
4.8.3 Novo Nordisk A/S Contraceptives Products Offered
4.8.4 Novo Nordisk A/S Contraceptives Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Novo Nordisk A/S Contraceptives Sales by Product in 2021
4.8.6 Novo Nordisk A/S Contraceptives Sales by End User in 2021
4.8.7 Novo Nordisk A/S Contraceptives Sales by Geographic Area in 2021
4.8.8 Novo Nordisk A/S Recent Development
4.9 ZiZhu
4.9.1 ZiZhu Corporation Information
4.9.2 ZiZhu Description, Business Overview
4.9.3 ZiZhu Contraceptives Products Offered
4.9.4 ZiZhu Contraceptives Sales, Revenue and Gross Margin (2017-2022)
4.9.5 ZiZhu Contraceptives Sales by Product in 2021
4.9.6 ZiZhu Contraceptives Sales by End User in 2021
4.9.7 ZiZhu Contraceptives Sales by Geographic Area in 2021
4.9.8 ZiZhu Recent Development
4.10 Baijingyu
4.10.1 Baijingyu Corporation Information
4.10.2 Baijingyu Description, Business Overview
4.10.3 Baijingyu Contraceptives Products Offered
4.10.4 Baijingyu Contraceptives Sales, Revenue and Gross Margin (2017-2022)
4.10.5 Baijingyu Contraceptives Sales by Product in 2021
4.10.6 Baijingyu Contraceptives Sales by End User in 2021
4.10.7 Baijingyu Contraceptives Sales by Geographic Area in 2021
4.10.8 Baijingyu Recent Development
4.11 Huazhong
4.11.1 Huazhong Corporation Information
4.11.2 Huazhong Description, Business Overview
4.11.3 Huazhong Contraceptives Products Offered
4.11.4 Huazhong Contraceptives Sales, Revenue and Gross Margin (2017-2022)
4.11.5 Huazhong Contraceptives Sales by Product in 2021
4.11.6 Huazhong Contraceptives Sales by End User in 2021
4.11.7 Huazhong Contraceptives Sales by Geographic Area in 2021
4.11.8 Huazhong Recent Development
4.12 Sine
4.12.1 Sine Corporation Information
4.12.2 Sine Description, Business Overview
4.12.3 Sine Contraceptives Products Offered
4.12.4 Sine Contraceptives Sales, Revenue and Gross Margin (2017-2022)
4.12.5 Sine Contraceptives Sales by Product in 2021
4.12.6 Sine Contraceptives Sales by End User in 2021
4.12.7 Sine Contraceptives Sales by Geographic Area in 2021
4.12.8 Sine Recent Development
4.13 Reckitt
4.13.1 Reckitt Corporation Information
4.13.2 Reckitt Description, Business Overview
4.13.3 Reckitt Contraceptives Products Offered
4.13.4 Reckitt Contraceptives Sales, Revenue and Gross Margin (2017-2022)
4.13.5 Reckitt Contraceptives Sales by Product in 2021
4.13.6 Reckitt Contraceptives Sales by End User in 2021
4.13.7 Reckitt Contraceptives Sales by Geographic Area in 2021
4.13.8 Reckitt Recent Development
4.14 AbbVie
4.14.1 AbbVie Corporation Information
4.14.2 AbbVie Description, Business Overview
4.14.3 AbbVie Contraceptives Products Offered
4.14.4 AbbVie Contraceptives Sales, Revenue and Gross Margin (2017-2022)
4.14.5 AbbVie Contraceptives Sales by Product in 2021
4.14.6 AbbVie Contraceptives Sales by End User in 2021
4.14.7 AbbVie Contraceptives Sales by Geographic Area in 2021
4.14.8 AbbVie Recent Development
4.15 Church & Dwight
4.15.1 Church & Dwight Corporation Information
4.15.2 Church & Dwight Description, Business Overview
4.15.3 Church & Dwight Contraceptives Products Offered
4.15.4 Church & Dwight Contraceptives Sales, Revenue and Gross Margin (2017-2022)
4.15.5 Church & Dwight Contraceptives Sales by Product in 2021
4.15.6 Church & Dwight Contraceptives Sales by End User in 2021
4.15.7 Church & Dwight Contraceptives Sales by Geographic Area in 2021
4.15.8 Church & Dwight Recent Development
4.16 The Cooper Companies
4.16.1 The Cooper Companies Corporation Information
4.16.2 The Cooper Companies Description, Business Overview
4.16.3 The Cooper Companies Contraceptives Products Offered
4.16.4 The Cooper Companies Contraceptives Sales, Revenue and Gross Margin (2017-2022)
4.16.5 The Cooper Companies Contraceptives Sales by Product in 2021
4.16.6 The Cooper Companies Contraceptives Sales by End User in 2021
4.16.7 The Cooper Companies Contraceptives Sales by Geographic Area in 2021
4.16.8 The Cooper Companies Recent Development
4.17 TherapeuticsMD
4.17.1 TherapeuticsMD Corporation Information
4.17.2 TherapeuticsMD Description, Business Overview
4.17.3 TherapeuticsMD Contraceptives Products Offered
4.17.4 TherapeuticsMD Contraceptives Sales, Revenue and Gross Margin (2017-2022)
4.17.5 TherapeuticsMD Contraceptives Sales by Product in 2021
4.17.6 TherapeuticsMD Contraceptives Sales by End User in 2021
4.17.7 TherapeuticsMD Contraceptives Sales by Geographic Area in 2021
4.17.8 TherapeuticsMD Recent Development
4.18 Afaxys
4.18.1 Afaxys Corporation Information
4.18.2 Afaxys Description, Business Overview
4.18.3 Afaxys Contraceptives Products Offered
4.18.4 Afaxys Contraceptives Sales, Revenue and Gross Margin (2017-2022)
4.18.5 Afaxys Contraceptives Sales by Product in 2021
4.18.6 Afaxys Contraceptives Sales by End User in 2021
4.18.7 Afaxys Contraceptives Sales by Geographic Area in 2021
4.18.8 Afaxys Recent Development
4.19 Mithra Pharmaceuticals
4.19.1 Mithra Pharmaceuticals Corporation Information
4.19.2 Mithra Pharmaceuticals Description, Business Overview
4.19.3 Mithra Pharmaceuticals Contraceptives Products Offered
4.19.4 Mithra Pharmaceuticals Contraceptives Sales, Revenue and Gross Margin (2017-2022)
4.19.5 Mithra Pharmaceuticals Contraceptives Sales by Product in 2021
4.19.6 Mithra Pharmaceuticals Contraceptives Sales by End User in 2021
4.19.7 Mithra Pharmaceuticals Contraceptives Sales by Geographic Area in 2021
4.19.8 Mithra Pharmaceuticals Recent Development
5 Breakdown Data by Type
5.1 Global Contraceptives Sales by Type (2017-2028)
5.1.1 Global Contraceptives Sales by Type (2017-2022)
5.1.2 Global Contraceptives Sales Forecast by Type (2023-2028)
5.1.3 Global Contraceptives Sales Market Share by Type (2017-2028)
5.2 Global Contraceptives Revenue Forecast by Type (2017-2028)
5.2.1 Global Contraceptives Revenue by Type (2017-2022)
5.2.2 Global Contraceptives Revenue Forecast by Type (2023-2028)
5.2.3 Global Contraceptives Revenue Market Share by Type (2017-2028)
5.3 Contraceptives Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by End User
6.1 Global Contraceptives Sales by End User (2017-2028)
6.1.1 Global Contraceptives Sales by End User (2017-2022)
6.1.2 Global Contraceptives Sales Forecast by End User (2023-2028)
6.1.3 Global Contraceptives Sales Market Share by End User (2017-2028)
6.2 Global Contraceptives Revenue Forecast by End User (2017-2028)
6.2.1 Global Contraceptives Revenue by End User (2017-2022)
6.2.2 Global Contraceptives Revenue Forecast by End User (2023-2028)
6.2.3 Global Contraceptives Revenue Market Share by End User (2017-2028)
6.3 Contraceptives Average Selling Price (ASP) by End User (2017-2028)
7 North America
7.1 North America Contraceptives Market Size YoY Growth 2017-2028
7.2 North America Contraceptives Market Facts & Figures by Country
7.2.1 North America Contraceptives Sales by Country (2017-2028)
7.2.2 North America Contraceptives Revenue by Country (2017-2028)
7.3 North America Contraceptives Sales by Type
7.4 North America Contraceptives Sales by End User
8 Asia-Pacific
8.1 Asia-Pacific Contraceptives Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Contraceptives Market Facts & Figures by Region
8.2.1 Asia-Pacific Contraceptives Sales by Region (2017-2028)
8.2.2 Asia-Pacific Contraceptives Revenue by Region (2017-2028)
8.3 Asia-Pacific Contraceptives Sales by Type
8.4 Asia-Pacific Contraceptives Sales by End User
9 Europe
9.1 Europe Contraceptives Market Size YoY Growth 2017-2028
9.2 Europe Contraceptives Market Facts & Figures by Country
9.2.1 Europe Contraceptives Sales by Country (2017-2028)
9.2.2 Europe Contraceptives Revenue by Country (2017-2028)
9.3 Europe Contraceptives Sales by Type
9.4 Europe Contraceptives Sales by End User
10 Latin America
10.1 Latin America Contraceptives Market Size YoY Growth 2017-2028
10.2 Latin America Contraceptives Market Facts & Figures by Country
10.2.1 Latin America Contraceptives Sales by Country (2017-2028)
10.2.2 Latin America Contraceptives Revenue by Country (2017-2028)
10.3 Latin America Contraceptives Sales by Type
10.4 Latin America Contraceptives Sales by End User
11 Middle East and Africa
11.1 Middle East and Africa Contraceptives Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Contraceptives Market Facts & Figures by Country
11.2.1 Middle East and Africa Contraceptives Sales by Country (2017-2028)
11.2.2 Middle East and Africa Contraceptives Revenue by Country (2017-2028)
11.3 Middle East and Africa Contraceptives Sales by Type
11.4 Middle East and Africa Contraceptives Sales by End User
12 Supply Chain and Sales Channel Analysis
12.1 Contraceptives Supply Chain Analysis
12.2 Contraceptives Key Raw Materials and Upstream Suppliers
12.3 Contraceptives Clients Analysis
12.4 Contraceptives Sales Channel and Sales Model Analysis
12.4.1 Contraceptives Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Contraceptives Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Contraceptives Distributors
13 Market Dynamics
13.1 Contraceptives Industry Trends
13.2 Contraceptives Market Drivers
13.3 Contraceptives Market Challenges
13.4 Contraceptives Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Contraceptives Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of Pills
Table 3. Major Manufacturers of Injectable
Table 4. Major Manufacturers of Condoms
Table 5. Major Manufacturers of Vaginal Rings
Table 6. Major Manufacturers of IUDs
Table 7. Major Manufacturers of Subdermal Implants
Table 8. Major Manufacturers of Others
Table 9. Global Contraceptives Market Size Growth by End User (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Contraceptives Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 11. Global Contraceptives Sales by Region (2017-2022) & (M Units)
Table 12. Global Contraceptives Sales Forecast by Region (2023-2028) & (M Units)
Table 13. Global Contraceptives Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Contraceptives Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 15. Global Contraceptives Sales by Manufacturer (2017-2022) & (M Units)
Table 16. Global Contraceptives Sales Share by Manufacturer (2017-2022)
Table 17. Contraceptives Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 18. Contraceptives Revenue Share by Manufacturer (2017-2022)
Table 19. Key Manufacturers Contraceptives Price (2017-2022) & (USD/Unit)
Table 20. Ranking of Global Top Contraceptives Manufacturers by Revenue (US$ Million) in 2021
Table 21. Global Contraceptives Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 22. Global Contraceptives by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Contraceptives as of 2021)
Table 23. Contraceptives Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Contraceptives Product Type
Table 25. Date of International Manufacturers Enter into Contraceptives Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Bayer AG Corporation Information
Table 28. Bayer AG Description and Business Overview
Table 29. Bayer AG Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 30. Bayer AG Contraceptives Product
Table 31. Bayer AG Contraceptives Sales Proportion of Contraceptives by Product in 2021
Table 32. Bayer AG Contraceptives Sales Proportion of Contraceptives by End User in 2021
Table 33. Bayer AG Contraceptives Sales Proportion of Contraceptives by Geographic Area in 2021
Table 34. Bayer AG Recent Development
Table 35. Pfizer, Inc Corporation Information
Table 36. Pfizer, Inc Description and Business Overview
Table 37. Pfizer, Inc Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 38. Pfizer, Inc Contraceptives Product
Table 39. Pfizer, Inc Contraceptives Sales Proportion of Contraceptives by Product in 2021
Table 40. Pfizer, Inc Contraceptives Sales Proportion of Contraceptives by End User in 2021
Table 41. Pfizer, Inc Contraceptives Sales Proportion of Contraceptives by Geographic Area in 2021
Table 42. Pfizer, Inc Recent Development
Table 43. Teva Pharmaceutical Industries Ltd Corporation Information
Table 44. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 45. Teva Pharmaceutical Industries Ltd Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 46. Teva Pharmaceutical Industries Ltd Contraceptives Product
Table 47. Teva Pharmaceutical Industries Ltd Contraceptives Sales Proportion of Contraceptives by Product in 2021
Table 48. Teva Pharmaceutical Industries Ltd Contraceptives Sales Proportion of Contraceptives by End User in 2021
Table 49. Teva Pharmaceutical Industries Ltd Contraceptives Sales Proportion of Contraceptives by Geographic Area in 2021
Table 50. Teva Pharmaceutical Industries Ltd Recent Development
Table 51. Merck & Co., Inc Corporation Information
Table 52. Merck & Co., Inc Description and Business Overview
Table 53. Merck & Co., Inc Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 54. Merck & Co., Inc Contraceptives Product
Table 55. Merck & Co., Inc Contraceptives Sales Proportion of Contraceptives by Product in 2021
Table 56. Merck & Co., Inc Contraceptives Sales Proportion of Contraceptives by End User in 2021
Table 57. Merck & Co., Inc Contraceptives Sales Proportion of Contraceptives by Geographic Area in 2021
Table 58. Merck & Co., Inc Recent Development
Table 59. Actavis, Inc. Corporation Information
Table 60. Actavis, Inc. Description and Business Overview
Table 61. Actavis, Inc. Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Actavis, Inc. Contraceptives Product
Table 63. Actavis, Inc. Contraceptives Sales Proportion of Contraceptives by Product in 2021
Table 64. Actavis, Inc. Contraceptives Sales Proportion of Contraceptives by End User in 2021
Table 65. Actavis, Inc. Contraceptives Sales Proportion of Contraceptives by Geographic Area in 2021
Table 66. Actavis, Inc. Recent Development
Table 67. Johnson & Johnson Corporation Information
Table 68. Johnson & Johnson Description and Business Overview
Table 69. Johnson & Johnson Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Johnson & Johnson Contraceptives Product
Table 71. Johnson & Johnson Contraceptives Sales Proportion of Contraceptives by Product in 2021
Table 72. Johnson & Johnson Contraceptives Sales Proportion of Contraceptives by End User in 2021
Table 73. Johnson & Johnson Contraceptives Sales Proportion of Contraceptives by Geographic Area in 2021
Table 74. Gedeon Richter Corporation Information
Table 75. Gedeon Richter Description and Business Overview
Table 76. Gedeon Richter Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Gedeon Richter Contraceptives Product
Table 78. Gedeon Richter Contraceptives Sales Proportion of Contraceptives by Product in 2021
Table 79. Gedeon Richter Contraceptives Sales Proportion of Contraceptives by End User in 2021
Table 80. Gedeon Richter Contraceptives Sales Proportion of Contraceptives by Geographic Area in 2021
Table 81. Novo Nordisk A/S Corporation Information
Table 82. Novo Nordisk A/S Description and Business Overview
Table 83. Novo Nordisk A/S Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 84. Novo Nordisk A/S Contraceptives Product
Table 85. Novo Nordisk A/S Contraceptives Sales Proportion of Contraceptives by Product in 2021
Table 86. Novo Nordisk A/S Contraceptives Sales Proportion of Contraceptives by End User in 2021
Table 87. Novo Nordisk A/S Contraceptives Sales Proportion of Contraceptives by Geographic Area in 2021
Table 88. ZiZhu Corporation Information
Table 89. ZiZhu Description and Business Overview
Table 90. ZiZhu Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 91. ZiZhu Contraceptives Product
Table 92. ZiZhu Contraceptives Sales Proportion of Contraceptives by Product in 2021
Table 93. ZiZhu Contraceptives Sales Proportion of Contraceptives by End User in 2021
Table 94. ZiZhu Contraceptives Sales Proportion of Contraceptives by Geographic Area in 2021
Table 95. Baijingyu Corporation Information
Table 96. Baijingyu Description and Business Overview
Table 97. Baijingyu Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 98. Baijingyu Contraceptives Product
Table 99. Baijingyu Contraceptives Sales Proportion of Contraceptives by Product in 2021
Table 100. Baijingyu Contraceptives Sales Proportion of Contraceptives by End User in 2021
Table 101. Baijingyu Contraceptives Sales Proportion of Contraceptives by Geographic Area in 2021
Table 102. Huazhong Corporation Information
Table 103. Huazhong Description and Business Overview
Table 104. Huazhong Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 105. Huazhong Contraceptives Product
Table 106. Huazhong Contraceptives Sales Proportion of Contraceptives by Product in 2021
Table 107. Huazhong Contraceptives Sales Proportion of Contraceptives by End User in 2021
Table 108. Huazhong Contraceptives Sales Proportion of Contraceptives by Geographic Area in 2021
Table 109. Sine Corporation Information
Table 110. Sine Description and Business Overview
Table 111. Sine Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. Sine Contraceptives Product
Table 113. Sine Contraceptives Sales Proportion of Contraceptives by Product in 2021
Table 114. Sine Contraceptives Sales Proportion of Contraceptives by End User in 2021
Table 115. Sine Contraceptives Sales Proportion of Contraceptives by Geographic Area in 2021
Table 116. Reckitt Corporation Information
Table 117. Reckitt Description and Business Overview
Table 118. Reckitt Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 119. Reckitt Contraceptives Product
Table 120. Reckitt Contraceptives Sales Proportion of Contraceptives by Product in 2021
Table 121. Reckitt Contraceptives Sales Proportion of Contraceptives by End User in 2021
Table 122. Reckitt Contraceptives Sales Proportion of Contraceptives by Geographic Area in 2021
Table 123. AbbVie Corporation Information
Table 124. AbbVie Description and Business Overview
Table 125. AbbVie Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 126. AbbVie Contraceptives Product
Table 127. AbbVie Contraceptives Sales Proportion of Contraceptives by Product in 2021
Table 128. AbbVie Contraceptives Sales Proportion of Contraceptives by End User in 2021
Table 129. AbbVie Contraceptives Sales Proportion of Contraceptives by Geographic Area in 2021
Table 130. Church & Dwight Corporation Information
Table 131. Church & Dwight Description and Business Overview
Table 132. Church & Dwight Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 133. Church & Dwight Contraceptives Product
Table 134. Church & Dwight Contraceptives Sales Proportion of Contraceptives by Product in 2021
Table 135. Church & Dwight Contraceptives Sales Proportion of Contraceptives by End User in 2021
Table 136. Church & Dwight Contraceptives Sales Proportion of Contraceptives by Geographic Area in 2021
Table 137. The Cooper Companies Corporation Information
Table 138. The Cooper Companies Description and Business Overview
Table 139. The Cooper Companies Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 140. The Cooper Companies Contraceptives Product
Table 141. The Cooper Companies Contraceptives Sales Proportion of Contraceptives by Product in 2021
Table 142. The Cooper Companies Contraceptives Sales Proportion of Contraceptives by End User in 2021
Table 143. The Cooper Companies Contraceptives Sales Proportion of Contraceptives by Geographic Area in 2021
Table 144. TherapeuticsMD Corporation Information
Table 145. TherapeuticsMD Description and Business Overview
Table 146. TherapeuticsMD Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 147. TherapeuticsMD Contraceptives Product
Table 148. TherapeuticsMD Contraceptives Sales Proportion of Contraceptives by Product in 2021
Table 149. TherapeuticsMD Contraceptives Sales Proportion of Contraceptives by End User in 2021
Table 150. TherapeuticsMD Contraceptives Sales Proportion of Contraceptives by Geographic Area in 2021
Table 151. Afaxys Corporation Information
Table 152. Afaxys Description and Business Overview
Table 153. Afaxys Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 154. Afaxys Contraceptives Product
Table 155. Afaxys Contraceptives Sales Proportion of Contraceptives by Product in 2021
Table 156. Afaxys Contraceptives Sales Proportion of Contraceptives by End User in 2021
Table 157. Afaxys Contraceptives Sales Proportion of Contraceptives by Geographic Area in 2021
Table 158. Mithra Pharmaceuticals Corporation Information
Table 159. Mithra Pharmaceuticals Description and Business Overview
Table 160. Mithra Pharmaceuticals Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 161. Mithra Pharmaceuticals Contraceptives Product
Table 162. Mithra Pharmaceuticals Contraceptives Sales Proportion of Contraceptives by Product in 2021
Table 163. Mithra Pharmaceuticals Contraceptives Sales Proportion of Contraceptives by End User in 2021
Table 164. Mithra Pharmaceuticals Contraceptives Sales Proportion of Contraceptives by Geographic Area in 2021
Table 165. Global Contraceptives Sales by Type (2017-2022) & (M Units)
Table 166. Global Contraceptives Sales Forecast by Type (2023-2028) & (M Units)
Table 167. Global Contraceptives Revenue by Type (2017-2022) & (US$ Million)
Table 168. Global Contraceptives Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 169. Global Contraceptives Sales by End User (2017-2022) & (M Units)
Table 170. Global Contraceptives Sales Forecast by End User (2023-2028) & (M Units)
Table 171. Global Contraceptives Revenue by End User (2017-2022) & (US$ Million)
Table 172. Global Contraceptives Revenue Forecast by End User (2023-2028) & (US$ Million)
Table 173. North America Contraceptives Sales by Country (2017-2022) & (M Units)
Table 174. North America Contraceptives Sales by Country (2023-2028) & (M Units)
Table 175. North America Contraceptives Revenue by Country (2017-2022) & (US$ Million)
Table 176. North America Contraceptives Revenue by Country (2023-2028) & (US$ Million)
Table 177. North America Contraceptives Sales by Type (2017-2022) & (M Units)
Table 178. North America Contraceptives Sales by End User (2017-2022) & (M Units)
Table 179. Asia-Pacific Contraceptives Sales by Region (2017-2022) & (M Units)
Table 180. Asia-Pacific Contraceptives Sales by Region (2023-2028) & (M Units)
Table 181. Asia-Pacific Contraceptives Revenue by Region (2017-
  • Global Drugs for Vulvovaginal Candidiasis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119
    According to our LPI (LP Information) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at US$ 798.8 million in 2023. With growing demand in downstream market, the Drugs for Vulvovaginal Candidiasis is forecast to a readjusted size of US$ 890 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Drugs for Vulvovaginal Candidiasis market. Drugs for Vulvovaginal Candidiasis are expected t......
  • Global Bacterial Vaginosis Drug Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Bacterial Vaginosis Drug market size was valued at US$ 896.6 million in 2023. With growing demand in downstream market, the Bacterial Vaginosis Drug is forecast to a readjusted size of US$ 1111.1 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Bacterial Vaginosis Drug market. Bacterial Vaginosis Drug are expected to show stable growth in the future ma......
  • Global Contraceptives Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 141
    According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period. The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation,......
  • Global Drugs for Vulvovaginal Candidiasis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108
    According to our (Global Info Research) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at USD 840.2 million in 2023 and is forecast to a readjusted size of USD 928.4 million by 2030 with a CAGR of 1.4% during review period. The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cu......
  • Global Menopausal Hot Flashes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Menopausal Hot Flashes market: According to our latest research, the global Menopausal Hot Flashes market looks promising in the next 5 years. As of 2022, the global Menopausal Hot Flashes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Hot flashes during menopause are symptoms of menopause. They refer to the warmth that occurs during the transition period of ......
  • Global Bacterial Vaginosis Drug Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 139
    Report Overview: This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs. The Global Bacterial Vaginosis Drug Market Size was estimated at USD 916.50 million in 2022 and is projected to reach USD 1127.18 million by 202......
  • Global Drugs for Vulvovaginal Candidiasis Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 122
    Report Overview: The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for a......
  • Global Bacterial Vaginosis Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Bacterial Vaginosis Drug market: According to our latest research, the global Bacterial Vaginosis Drug market looks promising in the next 5 years. As of 2022, the global Bacterial Vaginosis Drug market was estimated at USD 972.77 million, and it's anticipated to reach USD 1215.68 million in 2028, with a CAGR of 3.79% during the forecast years. Bacterial vaginosis (BV), also known as bacterial vaginosis, non-specific vaginitis is a disease that occurs......
  • Global Tocolysis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Tocolysis Drugs market: According to our latest research, the global Tocolysis Drugs market looks promising in the next 5 years. As of 2022, the global Tocolysis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tocolytics are medications used to suppress premature labor. Tocolytic therapy is provided when delivery would result in premature birth, postponi......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs